While this has been extensively studied in the context of tumour immune escape mechanisms and chronic viral infections (reviewed in40,41), thorough investigation of PD-1 and particularly PD-L1 on immune cell subsets in the context of MS is limited. The gene discussed is PDCD1; the disease is myeloid sarcoma.